729 results on '"Ahnen, Dennis J."'
Search Results
102. Nonsteroidal Anti-inflammatory Drug Use After 3 Years of Aspirin Use and Colorectal Adenoma Risk: Observational Follow-up of a Randomized Study
103. Targeting EGFR in Colorectal Cancer
104. Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia
105. Effect of a Mailed Brochure on Appointment-Keeping for Screening Colonoscopy: A Randomized Trial
106. Ornithine Decarboxylase Polymorphism Modification of Response to Aspirin Treatment for Colorectal Adenoma Prevention
107. First-Degree Relatives of Patients With Advanced Colorectal Adenomas Have An Increased Prevalence of Colorectal Cancer
108. Expression of SV-40 T antigen in the small intestinal epithelium of transgenic mice results in proliferative changes in the crypt and reentry of villus-associated enterocytes into the cell cycle but has no apparent effect oncellular differentiation programs and does not cause neoplastic transformation
109. Calcium Intake and Colon Cancer Biomarkers
110. Improving on‐time colorectal cancer screening through lead time messaging
111. Body Composition and Aspirin Dose for Colorectal Adenoma Prevention in a Randomized Clinical Trial
112. No Evidence for Posttreatment Effects of Vitamin D and Calcium Supplementation on Risk of Colorectal Adenomas in a Randomized Trial
113. Activating mutation in MET oncogene in familial colorectal cancer
114. Body mass index, calcium supplementation and risk of colorectal adenomas
115. Proliferation Happens
116. Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: Relationship to histologic and clinical characteristics
117. Improving on-time colorectal cancer screening through lead time messaging.
118. Quantifying the impact of adherence to screening strategies on colorectal cancer incidence and mortality.
119. NCCN Guidelines Insights: Colorectal Cancer Screening, Version 1.2018
120. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline
121. Our New President—David A. Lieberman, MD, AGAF, FACG
122. Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial
123. Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history
124. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017
125. Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design
126. Tissue markers of colon cancer risk
127. Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors
128. Association between adenoma location and risk of recurrence
129. Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival
130. Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome
131. Plasma lipoxin A 4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas
132. Colorectal cancer statistics, 2017
133. Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer
134. Shifts in the Fecal Microbiota Associated with Adenomatous Polyps
135. Regarding “Colorectal Cancer Screening Quality Measures: Beyond Colonoscopy”
136. Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial.
137. Body mass index, calcium supplementation and risk of colorectal adenomas.
138. How to capture a revolution
139. A Randomized Trial to Increase Colonoscopy Screening in Members of High-Risk Families in the Colorectal Cancer Family Registry and Cancer Genetics Network
140. Colorectal Cancer
141. Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes
142. Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial
143. Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology
144. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review
145. Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study
146. Chemoprevention of hereditary colon cancers: time for new strategies
147. Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome
148. Knowledge and Uptake of Genetic Counseling and Colonoscopic Screening Among Individuals at Increased Risk for Lynch Syndrome and their Endoscopists from the Family Health Promotion Project
149. Real-Time Characterization of Diminutive Colorectal Polyp Histology Using Narrow-Band Imaging: Implications for the Resect and Discard Strategy
150. Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.